Latest Stenocare News & Updates

See the latest news and media coverage for Stenocare. We track all announcements, press releases, and industry mentions in real time, all in one place.

Stenocare

Danish pharmaceutical medical cannabis supplier

stenocare.com

Headquarters: Kirke Værløse, Denmark
Founded year: 2017
Company type: Public company
Number of employees: 5–10

Last updated Today

Latest news about Stenocare

In short: Stenocare reported strong sales growth and reached EBITDA break-even milestones throughout 2025 and Q1 2026 following strategic acquisitions.

Company announcements

May 8 Stenocare

Stenocare delivers strong Q1 results

Sales rose 15% to 3 million DKK with positive EBITDA and operating cash flow. Integration of CannGros strengthens market position. Expects growth and break-even in 2026.

March 26 Stenocare

Stenocare publishes its Annual Report 2025

The report highlights record year, strong sales growth, EBITDA improvement, and CannGros acquisition for 2026 break-even.

February 11 Stenocare

Stenocare enters France for first-mover advantage

Stenocare partners with ICMF and Movianto, submitting ASTRUM 10-10 oil dossier to French authorities. France expects medical cannabis legalization in 2026.

January 27 Stenocare

Stenocare partners with WEECO Pharma in Germany

They launch the new Astrum Oil brand to accelerate sales and patient reach. Rolf Steno and WEECO CEO Tony Schroeter shake hands.

Media coverage

May 7 FinanzNachrichten

Stenocare A/S: Interim report first quarter 2026

STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENOSTENOCARE A/S ("STENOCARE") today announces its results for the period 01.01.2026 - 31.03.2026. The report, which...

March 26 Økonomisk Ugebrev

STENOCARE A/S publishes Annual Report 2025

STENOCARE A/S published the annual report for 2025, which shows three quarters with positive EBITDA and a record net revenue of 7.0 million DKK, which is a...

February 25 Økonomisk Ugebrev

Stenocare reached EBITDA breakeven in Q4

Stenocare A/S announces its results for 2025. The year's net revenue rose to 7,021 t.kr. from 2,232 t.kr. in 2024. The year's EBITDA was -1,742 t.kr., but...

17 November 2025 Økonomisk Ugebrev

STENOCARE A/S acquires CannGros ApS and adds DKK 4-6 million in annual revenue and supports the goal of breaking even in 2026 | Economic Weekly

Stenocare A/S has acquired CannGros ApS from DanCann Pharma A/S. This adds DKK 4-6 million in annual revenue. The acquisition supports Stenocare's goal of financial balance...

Never miss news about Stenocare

Track Stenocare and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Stenocare competitors & trending companies

Browse news for competitors to Stenocare and other trending companies.